Nigeria
Nigeria has begun clinical trials for the two covid-19 vaccines developed in the country.
Chairman of the presidential task force on covid-19, Boss Mustapha told reporters last week that the vaccines will be used after the completion of trials and obtaining of relevant certification.
The vaccines were developed by Nigerian scientists, and described as a scientific breakthrough which will ‘’ boost the morale and image of the medical industry in the country’’.
Mustapha asked all relevant agencies to provide the necessary support for the smooth running of the remaining protocols for the certification of the vaccines.
So far Africa’s most populous nation has taken delivery of 4 million doses of the Oxford-Astrazeneca vaccines from the Covax initiative. The country plans to receive 16 million doses.
Earlier this year, the Federal government announced that it had pumped some $25 million to develop local vaccines to battle the coronavirus.
As at the time of filing this report, Nigeria has recorded 163,000 coronvarius cases, 152,000 have recovered and some 2,058 covid-19 related deaths have been registered.
01:43
Trial of more than 1,200 people accused of illegal gold mining opens in Conakry
Go to video
Egypt detains journalist Lina Attalah after court ruling
00:53
Tanzania's jailed opposition leader Tundu Lissu begins hunger strike
01:33
Defence seeks acquittal of doctor in death of Argentina's Maradona
01:00
Germany: Supporters rally in Hamburg as trial opens over Nord Stream pipeline blasts
02:10
Thirteen sentenced to jail in France over deadly Channel migrant boat sinking